SIOPEL 6: A multicenter open-label randomized phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard-risk hepatoblastoma (SR-HB).

Affiliation auteurs!!!! Error affiliation !!!!
TitreSIOPEL 6: A multicenter open-label randomized phase III trial of the efficacy of sodium thiosulphate (STS) in reducing ototoxicity in patients receiving cisplatin (Cis) monotherapy for standard-risk hepatoblastoma (SR-HB).
Type de publicationJournal Article
Year of Publication2014
AuteursMaibach R, Childs M, Rajput K, Neuwelt EA, Roebuck D, Sullivan MJames, Laithler V, Ronghe W, Lockwood L, dall'Igna P, Hiyama E, Brichard B, Skeen J, Gonzales MElena Mate, Fabre M, Perilongo G, Czauderna P, Morland B, Brock P
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume32
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2014.32.15_suppl.tps10094